PLX Pharma
Houston, US
Biotech
Founders & leadership
UM
Upendra MarathiSenior Vice President
KC
Kirk CalhounDirector
BC
Bob CasaleDirector
GB
Gary BalkemaDirector
GM
Gary MossmanCOO
RZ
Ron ZimmermanSenior Adviser
DJ
David JordenCFO, Secretary
JH
John Hadden IIDirector
MV
Michael ValentinoDirector, Executive Chairman
NG
Natasha GiordanoDirector, President, CEO
DJ
David J. JordenExecutive Officer
DJ
David J. LuciDirector
Reported raises · per SEC filings
Form D private placements$18MraisedNov 2020 · 25 investors · Pharmaceuticals
Rule 506(b)$8MraisedMay 2020 · 3 investors · Pharmaceuticals
Rule 506(b)$15MraisedMar 2019 · 2 investors · Pharmaceuticals
Rule 506(b)$18.2MraisedJun 2017 · 37 investors · Pharmaceuticals
Rule 506(b)$1.3MraisedMar 2016 · 27 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.